SavedAdd your journal

Journals / MN Oftalmoloji / 2016 / Cilt: 23 - Sayı: 1

Unilateral Acute Anterior Uveitis After Zoledronic Acid Infusion

Zoledronik Asit İnfüzyonu Sonrası Gelişen Unilateral Akut Ön Üveit

Cem ÖZGÖNUL
Gökçen GÖKÇE
Tarkan MUMCUOĞLU
Pages
52–54
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These diseases may cause serious ocular injury, however they can be successfully treated with topical steroids.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We report a case with unilateral acute anterior uveitis after zoledronic acid infusion for the treatment of osteoporosis.
📊
Key Findings & Data:A 57 year old female patient was admitted with complaints of redness in her left eye.
💡
Conclusion & Impact:These diseases may cause serious ocular injury, however they can be successfully treated with topical steroids.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

We report a case with unilateral acute anterior uveitis after zoledronic acid infusion for the treatment of osteoporosis. A 57 year old female patient was admitted with complaints of redness in her left eye. Ciliary injection, wrinkles and folds in the Descemet's membrane due to corneal edema, keratic precipitates, +3 cells in anterior chamber, intensive fibrin reaction, and all around posterior synechia was noted in the left eye by biomicroscopy. She was treated with topical corticosteroids. On the fifth day of treatment, all clinical findings had disappeared. Zoledronic acid treatment may lead to inflammatory eye diseases. These diseases may cause serious ocular injury, however they can be successfully treated with topical steroids.

Özet

Zoledronik Asit İnfüzyonu Sonrası GelişenUnilateral Akut Ön ÜveitCem ÖZGÖNÜL*, Gökçen GÖKÇE**, Tarkan MUMCUOĞLU***Bu makalede osteoporoz tedavisi için uygulanan zoledronik asit infüzyonu sonrası gelişen unilateral akut ön üveit olgusu sunulmuştur. Solgözündeki kızarıklık şikayetiyle 57 yaşındaki kadın hasta polikliniğimize başvurdu. Biyomikroskopide sol gözde, siliyer enjeksiyon, kornea ödemine bağlı Descemet membran kırışıklıkları, keratik presipitatlar, ön kamarada +3 hücre ve +3 flare, yoğun fibrin reaksiyonu ve çepeçevre arka sineşiler mevcuttu. Hastaya topikal kortikosteroid başlandı. Beşinci günde tüm klinik bulgular iyileşmişti. Zoledronik asit tedavisi enflamatuar göz hastalıklarına sebep olabilmektedir. Göze ciddi derecede hasar verebilecek bu hastalıklar topikal steroid tedavisi ile başarıyla tedaviedilebilmektedir.

🔖

Cite This Article

ÖZGÖNUL, C., GÖKÇE, G., MUMCUOĞLU, T. (2016). Unilateral Acute Anterior Uveitis After Zoledronic Acid Infusion. MN Oftalmoloji, Cilt: 23 - Sayı: 1, 52–54. https://ajindex.com/articles/295519

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Berenson JR, Hillner BE, Kyle RA, et al. American Society of Clinical Oncology clinical practice guidelines: the role of bispho- sphonates in multiple myeloma. J Clin Oncol 2002;20:3719-36.
  2. Dalle Carbonare L, Zanatta M, Gasparetto A, Valenti MT. Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management. Drug Healthc Patient Saf 2010;2:121- 37. Conte P, Guarneri V. Safety of intravenous and oral bisphospho- nates and compliance with dosing regimens. Oncologist 2004;4: 28-37.
  3. Durnian JM, Olujohungbe A, Kyle G. Bilateral acute uveitis and conjunctivitis after zoledronic acid therapy. Eye (Lond) 2005;19: 221-2.
  4. Woo TC, Joseph DJ, Wilkinson R. Serious ocular complications of zoledronate. Clin Oncol 2006;18:545-6.
  5. Kaur H, Uy C, Kelly J, Moses AM. Orbital inflammatory disease in a patient treated with zoledronate. Endocr Pract 2011;17. Sauty A, Pecherstorfer M, Zimmer-Roth I, et al. Interleukin-6 and tumor necrosis factor alpha levels after bisphosphonates treatment in vitro and in patients with malignancy. Bone 1996;18:133-9.
  6. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
  7. Patel DV, Horne A, House M, Reid IR, McGhee CN. The inci- dence of acute anterior uveitis after intravenous zoledronate. Ophthalmology 2013;120:773-6.
  8. Banal F, Briot K, Ayoub G, Dougados M, Roux C. Unilateral an- terior uveitis complicating zoledronic acid therapy in prostate cancer. J Rheumatol 2008;35:2458-9.
  9. Belliveau MJ, Almeida D, Urton TE. Acute anterior uveitis fol- lowing zoledronic acid infusion for osteoporosis. Can J Opht hal - mol 2012;47:e22-e23.